Zubsolv and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Zubsolv (buprenorphine hydrochloride; naloxone hydrochloride), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Suboxone, and have Drug dependence.

The phase IV clinical study analyzes which people have Drowsiness when taking Zubsolv. It is created by eHealthMe based on reports of 1,003 people who have side effects when taking Zubsolv from the FDA, and is updated regularly.

What is Zubsolv?

Zubsolv has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 1,029 Zubsolv users. Check the latest studies of Zubsolv.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 15, 2026

1,003 people reported to have side effects when taking Zubsolv.
Among them, 29 people (2.89%) have Drowsiness.

Among these 29 people:

How long have people been on Zubsolv when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Zubsolv? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Drowsiness when taking Zubsolv? *

What are other drugs people take besides Zubsolv? *

What are other side effects people have besides Drowsiness? *

Weakness: 5 people, 17.24%
Nausea (feeling of having an urge to vomit): 5 people, 17.24%
Agitation (state of anxiety or nervous excitement): 4 people, 13.79%
Dysstasia (difficulty in standing): 4 people, 13.79%
Tachyphrenia (abnormally rapid mental activity): 4 people, 13.79%
Fatigue (feeling of tiredness): 4 people, 13.79%
Skin Discoloration: 4 people, 13.79%
Dizziness: 4 people, 13.79%
Logorrhea: 4 people, 13.79%
Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood): 4 people, 13.79%

What are the existing conditions these people have? *

Drug Dependence: 11 people, 37.93%
Pain: 3 people, 10.34%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.90%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.90%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 3.45%
Muscle Aches (muscle pain): 1 person, 3.45%
High Blood Pressure: 1 person, 3.45%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 1 person, 3.45%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 3.45%
Abdominal Discomfort: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Zubsolv and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zubsolv:

Zubsolv (1,029 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

How severe was Drowsiness and when was it recovered:

Drowsiness in Zubsolv

Expand to all the drugs that have ingredients of buprenorphine hydrochloride; naloxone hydrochloride:

Drowsiness and drugs with ingredients of buprenorphine hydrochloride; naloxone hydrochloride (948 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zubsolv:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride (the active ingredients of Zubsolv) and Zubsolv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.